Operating
Other royalty cash collections
Royalty Pharma Other royalty cash collections increased by 15.5% to $33.62M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $31.76M to $33.62M. Over 4 years (FY 2021 to FY 2025), Other royalty cash collections shows an upward trend with a 26.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase indicates broader revenue diversification beyond core royalty assets.
Detailed definition
Captures cash collections from royalty arrangements that do not fall under the primary financial or intangible asset cat...
Peer comparison
Similar to other operating income or miscellaneous revenue streams in pharmaceutical licensing firms.
Metric ID:
operating_proceeds_from_cash_collections_from_other_roya_bab9b3Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.27M | $13.38M | $16.65M | $17.35M | $15.37M | $18.89M | $18.28M | $19.69M | $39.87M | $24.72M | $74.57M | $26.31M | $23.21M | $29.81M | $29.51M | $31.76M | $24.05M | $29.11M | $29.1M | $33.62M |
| QoQ Change | — | +84.1% | +24.5% | +4.1% | -11.4% | +22.9% | -3.2% | +7.7% | +102.5% | -38.0% | +201.6% | -64.7% | -11.8% | +28.4% | -1.0% | +7.6% | -24.3% | +21.0% | -0.0% | +15.5% |
| YoY Change | — | — | — | — | +111.5% | +41.2% | +9.8% | +13.5% | +159.4% | +30.9% | +307.8% | +33.7% | -41.8% | +20.6% | -60.4% | +20.7% | +3.6% | -2.4% | -1.4% | +5.8% |
Range$7.27M – $74.57M
CAGR+38.1%
Avg YoY Growth+40.8%
Median YoY Growth+17.0%
Other royalty cash collections at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's other royalty cash collections?
- Royalty Pharma (RPRX) reported other royalty cash collections of $33.62M in Q1 2026.
- How has Royalty Pharma's other royalty cash collections changed year-over-year?
- Royalty Pharma's other royalty cash collections increased by 5.8% year-over-year, from $31.76M to $33.62M.
- What is the long-term trend for Royalty Pharma's other royalty cash collections?
- Over 4 years (2021 to 2025), Royalty Pharma's other royalty cash collections has grown at a 26.8% compound annual growth rate (CAGR), from $44.12M to $114.02M.
- What does other royalty cash collections mean?
- Cash received from miscellaneous or secondary royalty arrangements.